Analgesics in Israel
Euromonitor International's Analgesics in Israel market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 37 | Publication date: May 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Systemic analgesics; Topical analgesics/anaesthetic
Table of contents
OTC HEALTHCARE IN ISRAEL : MARKET INSIGHT
EXECUTIVE SUMMARY
2008 continues positive growth rates similar to the review period
Demand for more specific treatments leads to new innovations and launches
Private label benefits from unique market structure
GSL revolution did not bring expected results
Economic slowdown aside, some sectors are expected to see strong growth
KEY TRENDS AND DEVELOPMENTS
Unusual market structure with OTC drugs falling in the “health basket”
Increased private label activity
Specific drugs answer consumer demand for specification
GSL revolution failed to impact the retail market as expected
Economic slowdown is expected only in 2009
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication and Preventive Medicine
Generics
Switches
Summary 1 OTC Healthcare Switches 2005-2007
DEFINITIONS
Summary 2 Research Sources
LOCAL COMPANY PROFILES - ISRAEL
DEXXON LTD - OTC HEALTHCARE - ISRAEL
STRATEGIC DIRECTION
KEY FACTS
Summary 3 Dexxon Ltd: Key Facts
Summary 4 Dexxon Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 5 Dexxon Ltd: Competitive Position 2008
NEW-PHARM DRUGSTORES LTD - OTC HEALTHCARE - ISRAEL
STRATEGIC DIRECTION
KEY FACTS
Summary 6 New-Pharm Drugstores Ltd: Key Facts
Summary 7 New-Pharm Drugstores Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
REKAH PHARMACEUTICAL PRODUCTS LTD - OTC HEALTHCARE - ISRAEL
STRATEGIC DIRECTION
KEY FACTS
Summary 8 Rekah Pharmaceutical Products Ltd: Key Facts
Summary 9 Rekah Pharmaceutical Products Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 10 Rekah Pharmaceutical Products Ltd: Competitive Position 2008
SUPER-PHARM (ISRAEL) LTD - OTC HEALTHCARE - ISRAEL
STRATEGIC DIRECTION
KEY FACTS
Summary 11 Super Pharm Israel Ltd: Key Facts
Summary 12 Super Pharm Israel Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
TEVA PHARMACEUTICAL INDUSTRIES LTD - OTC HEALTHCARE - ISRAEL
STRATEGIC DIRECTION
KEY FACTS
Summary 13 Teva Pharmaceutical Industries Ltd: Key Facts
Summary 14 Teva Pharmaceutical Industries Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 Teva Pharmaceutical Industries Ltd: Competitive Position 2008
TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD - OTC HEALTHCARE - ISRAEL
STRATEGIC DIRECTION
KEY FACTS
Summary 16 Trima Israel Pharmaceutical Products Maabarot Ltd: Key Facts
Summary 17 Trima Israel Pharmaceutical Products Maabarot Ltd: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 18 Trima Israel Pharmaceutical Products Maabarot Ltd Competitive Position 2008
ANALGESICS IN ISRAEL
HEADLINES
TRENDS
SWITCHES
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 16 Analgesics Company Shares by Value 2004-2008
Table 17 Analgesics Brand Shares by Value 2005-2008
Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013